
This episode discusses the FDA's approval of Biogen's Alzheimer's drug, the implications of remote work policies at major tech companies, and the dynamics of the cryptocurrency community.
The hosts, Chamath Palihapitiya, David Sacks, and David Friedberg, engage in a detailed conversation about Biogen's Alzheimer's drug, Aducanumab, which was approved despite concerns over its efficacy. They highlight the controversy surrounding the FDA's decision, including the unanimous vote against approval from the advisory panel and the high cost of the drug.
They also touch on the broader implications of remote work policies at companies like Apple, Google, and Facebook, discussing how these policies affect productivity and employee morale. The conversation reveals differing opinions on the necessity and effectiveness of returning to the office.
Additionally, the episode covers the rise of Bitcoin maximalism and the toxicity within the cryptocurrency community, as well as the cultural implications of wealth inequality and taxation in the U.S.
Overall, the episode provides a mix of insights into healthcare, corporate culture, and the evolving landscape of cryptocurrency.
The episode covers Biogen's Alzheimer's drug approval, remote work policies, and toxicity in the cryptocurrency community.

This episode stands out for the following:
Should we allow pharma companies to charge whatever they want?E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
Everyone wants that lottery ticket; there's no downside and only upside.E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
The future artillery is going to be from space.E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
It's like in jail where the good inmates get their own stuff.E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
The truth is a little bit more nuanced than I think.E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more
We’re all naval gazing on this, China’s progress, China is 996.E35: Biogen's controversial Alzheimer's drug approval, the billionaire space race, Bitcoin & more